Steve Chesney analyst ATLANTIC EQUITIES

Currently out of the existing stock ratings of Steve Chesney, 22 are a BUY (46.81%), 6 are a SELL (12.77%), 19 are a HOLD (40.43%).

Steve Chesney

Work Performance Price Targets & Ratings Chart

Analyst Steve Chesney works at ATLANTIC EQUITIES with a stock forecast success ratio of 62.78% fulfilled within 324.78 days on average.

Steve Chesney’s has documented 93 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 06-Feb-2024.

Wall Street Analyst Steve Chesney

Analyst best performing recommendations are on JNJ (JOHNSON & JOHNSON).
The best stock recommendation documented was for JNJ (JOHNSON & JOHNSON) at 8/4/2023. The price target of $170 was fulfilled within 3 days with a profit of $3.51 (2.11%) receiving and performance score of 7.03.

Average potential price target upside

BIIB Biogen ABBV AbbVie AMGN Amgen BMY Bristol-Myers Squibb Company JNJ Johnson & Johnson MRK Merck mpany IDXX IDEXX Laboratories PFE Pfizer ZTS Zoetis

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

277

$53.68 (24.04%)

335

4 days ago

24/33 (72.73%)

$54.52 (24.51%)

135

Buy

305

$81.68 (36.58%)

350

6 days ago

14/22 (63.64%)

$85.79 (39.14%)

228

Hold

250

$26.68 (11.95%)

276

10 days ago

3/15 (20%)

$30.92 (14.11%)

86

Buy

364

$140.68 (62.99%)

363

12 days ago

39/56 (69.64%)

$143.26 (64.90%)

112

Buy

325

$101.68 (45.53%)

325

12 days ago

1/8 (12.5%)

$104.26 (47.23%)

253

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Steve Chesney is most bullish on?

Potential upside of $2.34 has been obtained for BMY (BRISTOL-MYERS SQUIBB COMPANY)

What Year was the first public recommendation made by Steve Chesney?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?